Peter W Hunt Selected Research

Thymidine

1/2018

Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter W Hunt Research Topics

Disease

39	HIV Infections (HIV Infection) 03/2023 - 12/2006
37	Inflammation (Inflammations) 05/2023 - 04/2010
34	Acquired Immunodeficiency Syndrome (AIDS) 05/2024 - 03/2010
27	Infections 11/2023 - 01/2012
20	Viremia 01/2023 - 09/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2010
10	Disease Progression 06/2022 - 03/2006
7	Tuberculosis (Tuberculoses) 03/2024 - 09/2011
5	Macular Degeneration (Age-Related Maculopathy) 05/2024 - 01/2018
5	Neoplasms (Cancer) 10/2023 - 03/2010
4	Myocardial Infarction 01/2023 - 09/2009
4	Fibrosis (Cirrhosis) 01/2018 - 04/2015
4	Atherosclerosis 06/2012 - 06/2009
3	Pneumonia (Pneumonitis) 03/2024 - 01/2019
3	COVID-19 10/2022 - 01/2022
3	Hepatitis C 01/2019 - 11/2013
3	Sepsis (Septicemia) 01/2019 - 01/2017
2	Cataract (Cataracts) 05/2024 - 01/2022
2	Fatigue 01/2023 - 07/2022
2	Alcoholism (Alcohol Abuse) 03/2022 - 12/2015
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Coinfection 01/2022 - 01/2017
2	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2021 - 11/2015
2	Insulin Resistance 01/2019 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Persistent Infection 01/2019 - 01/2017
2	Necrosis 01/2018 - 01/2012
2	Hypertension (High Blood Pressure) 12/2016 - 10/2015
2	Carotid Artery Diseases 02/2016 - 06/2012
1	Latent Tuberculosis 01/2024
1	Rupture 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Coronary Thrombosis 01/2023
1	Nematode Infections 04/2022
1	Zika Virus Infection 01/2022
1	Genetic Risk Score 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Tics (Tic) 01/2020
1	Lung Injury 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Ischemic Stroke 01/2019

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2010
14	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2004
12	KynurenineIBA 01/2024 - 07/2013
11	Interleukin-6 (Interleukin 6)IBA 05/2024 - 07/2013
10	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 07/2013
9	C-Reactive ProteinIBA 05/2024 - 04/2012
9	Lipopolysaccharide ReceptorsIBA 05/2024 - 10/2014
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2011
6	CytokinesIBA 10/2022 - 07/2013
5	AntigensIBA 01/2024 - 04/2012
5	fibrin fragment D (D-dimer)IBA 05/2023 - 10/2014
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2017
4	Immunoglobulin G (IgG)IBA 01/2023 - 06/2012
4	VaccinesIBA 12/2014 - 05/2008
4	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2006
3	InterleukinsIBA 03/2024 - 01/2019
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2024 - 10/2014
3	LipidsIBA 03/2023 - 10/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 05/2010
3	Fatty Acid-Binding ProteinsIBA 01/2022 - 01/2019
3	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 03/2006
3	Retinaldehyde (Retinal)IBA 01/2019 - 07/2017
2	LigandsIBA 03/2024 - 05/2008
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023 - 07/2022
2	Carbon MonoxideIBA 01/2023 - 01/2021
2	phosphatidylethanolIBA 03/2022 - 12/2015
2	Neutralizing AntibodiesIBA 01/2022 - 12/2016
2	InterferonsIBA 01/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2010
2	AntibodiesIBA 12/2019 - 05/2019
2	BilirubinIBA 01/2019 - 01/2018
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 01/2018
2	abacavir (Ziagen)FDA Link 10/2017 - 09/2009
1	Interleukin-18 (Interleukin 18)IBA 05/2024
1	InflammasomesIBA 05/2024
1	Chemokine CX3CL1IBA 05/2024
1	ChemokinesIBA 03/2024
1	staphylococcal enterotoxin BIBA 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023
1	Angiopoietin-2IBA 01/2023
1	4-toluenesulfonyl fluoride (TSF)IBA 04/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	T Cell Transcription Factor 1IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Integrase InhibitorsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	CHDI-340246IBA 01/2019

Therapy/Procedure

47	Therapeutics 03/2024 - 09/2003
34	Art Therapy 01/2022 - 03/2010
6	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 10/2010
1	Bed Rest (Bedrest) 11/2023